| Literature DB >> 24900339 |
Débora G Salomón1, Silvina M Grioli1, Maximiliano Buschiazzo1, Evangelina Mascaró2, Cristian Vitale2, Gabriel Radivoy2, Manuel Perez3, Yagamare Fall3, Enrique A Mesri4, Alejandro C Curino1, María M Facchinetti1.
Abstract
Here, we describe the design and synthesis of diethyl [(5Z,7E)-(1S,3R)-1,3-dihydroxy-9,10-secochola-5,7,10(19)-trien-23-in-24-yl] phosphonate (compound 10), which combines the low calcemic properties of phosphonates with the decreased metabolic inactivation due to the presence of a triple bond in C-24 and studied its in vitro effects on several cancer cell lines and its in vivo effects on blood calcium levels. We demonstrate that this compound is a potent antiproliferative vitamin D analogue, showing lack of calcemic effects in vivo.Entities:
Keywords: 1α,25-(OH)2 vitamin D3; alkynylphosphonate analogues; cancer; cellular proliferation; hypercalcemia
Year: 2011 PMID: 24900339 PMCID: PMC4018101 DOI: 10.1021/ml200034w
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345